BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

241 hedge funds and large institutions have $1.08B invested in BioCryst Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 38 closing their positions.

Holders
241
Holders Change
+3
Holders Change %
+1.26%
% of All Funds
3.51%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
43
Increased
83
Reduced
69
Closed
38
Calls
$8.76M
Puts
$9.04M
Net Calls
-$281K
Net Calls Change
+$1.22M

Top Buyers

1
CP
1
Caligan Partners
New York
$28.4M
2
DM
2
Deerfield Management
New York
$50.3M
3
Alkeon Capital Management
3
Alkeon Capital Management
New York
$43.9M
4
KCM
4
Kynam Capital Management
New Jersey
$54.5M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$27.8M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$468K
2
State Street
2
State Street
Massachusetts
$57.8M
3
B
3
Braidwell
Connecticut
$0
4
Citigroup
4
Citigroup
New York
$723K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$123M 19,956,255 +1,515,526 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$116M 18,769,493 +1,092,726 +6%
ACA
3
Avoro Capital Advisors
New York
$77.7M 12,570,000 -480,000 -4%
State Street
4
State Street
Massachusetts
$57.8M 9,346,799 -8,130,545 -47%
KCM
5
Kynam Capital Management
New Jersey
$54.5M 8,826,710 +2,299,219 +35%
DM
6
Deerfield Management
New York
$50.3M 8,135,804 +3,140,804 +63%
Alkeon Capital Management
7
Alkeon Capital Management
New York
$43.9M 7,099,484 +3,000,000 +73%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$29.1M 4,710,277 +310,006 +7%
CP
9
Caligan Partners
New York
$28.4M 4,598,737 +3,840,235 +506%
Nuveen Asset Management
10
Nuveen Asset Management
Illinois
$27.8M 4,495,385 +1,875,524 +72%
RM
11
RP Management
New York
$23.8M 3,846,154 – –
RSCM
12
Rock Springs Capital Management
Maryland
$22.4M 3,619,258 +123,002 +4%
GKIM
13
GW&K Investment Management
Massachusetts
$21M 3,404,700 -49,208 -1%
Fisher Asset Management
14
Fisher Asset Management
Washington
$17.7M 2,856,703 -27,916 -1%
Voloridge Investment Management
15
Voloridge Investment Management
Florida
$16M 2,590,861 +1,623,139 +168%
Goldman Sachs
16
Goldman Sachs
New York
$15.6M 2,530,259 +604,894 +31%
BFM
17
Boothbay Fund Management
New York
$13.2M 2,135,263 +1,672,929 +362%
RHJA
18
Rice Hall James & Associates
California
$12.9M 2,079,641 -71,904 -3%
CCM
19
Cutter Capital Management
New York
$12.2M 1,975,298 -130,161 -6%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$12M 1,948,984 +1,818,209 +1,390%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$12M 1,942,279 +107,203 +6%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$11.9M 1,919,512 -553,900 -22%
Ameriprise
23
Ameriprise
Minnesota
$11.5M 1,865,623 -469,568 -20%
Stifel Financial
24
Stifel Financial
Missouri
$11.4M 1,843,652 -284 -0%
Charles Schwab
25
Charles Schwab
California
$11M 1,785,134 +53,331 +3%
1
2 3 4 5